These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 3977951)
1. Protein binding as a component of drug interaction in cellular pharmacokinetic studies. Effects of probenecid on transport and accumulation of methotrexate in Ehrlich ascites tumor cells in vitro. Gewirtz DA; Holt SA Biochem Pharmacol; 1985 Mar; 34(6):747-54. PubMed ID: 3977951 [TBL] [Abstract][Full Text] [Related]
2. Increased accumulation of methotrexate by murine tumor cells in vitro in the presence of probenecid which is mediated by a preferential inhibition of efflux. Sirotnak FM; Moccio DM; Young CW Cancer Res; 1981 Mar; 41(3):966-70. PubMed ID: 7459883 [TBL] [Abstract][Full Text] [Related]
3. The issues of transport multiplicity and energetics pertaining to methotrexate efflux in L1210 cells addressed by an analysis of cis and trans effects of inhibitors. Sirotnak FM; O'Leary DF Cancer Res; 1991 Mar; 51(5):1412-7. PubMed ID: 1997179 [TBL] [Abstract][Full Text] [Related]
4. Interactions between 7-hydroxymethotrexate and methotrexate at the cellular level in the Ehrlich ascites tumor in vitro. Fabre G; Matherly LH; Fabre I; Cano JP; Goldman ID Cancer Res; 1984 Mar; 44(3):970-5. PubMed ID: 6692419 [TBL] [Abstract][Full Text] [Related]
5. Augmentation of the intracellular levels of polyglutamyl derivatives of methotrexate by vincristine and probenecid in Ehrlich ascites tumor cells. Fry DW; Yalowich JC; Goldman ID Cancer Res; 1982 Jul; 42(7):2532-6. PubMed ID: 6177396 [TBL] [Abstract][Full Text] [Related]
6. Serum protein reduction of the enhancement of methotrexate accumulation by vincristine and 4'-demethylepipodophyllotoxin in the Ehrlich ascites tumor cell in vitro. Gewirtz DA Cancer Res; 1985 Dec; 45(12 Pt 1):6290-2. PubMed ID: 4063980 [TBL] [Abstract][Full Text] [Related]
7. Characteristics of the accumulation of methotrexate polyglutamate derivatives in Ehrlich ascites tumor cells and isolated rat hepatocytes. Fry DW; Gewirtz DA; Yalowich JC; Goldman ID Adv Exp Med Biol; 1983; 163():215-34. PubMed ID: 6193686 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of renal tubular transport of methotrexate by probenecid. Bourke RS; Chheda G; Bremer A; Watanabe O; Tower DB Cancer Res; 1975 Jan; 35(1):110-6. PubMed ID: 1109785 [TBL] [Abstract][Full Text] [Related]
9. Interaction of probenecid with methotrexate transport and release in the isolated rat hepatocyte in suspension. Gewirtz DA; Plotkin JH; Randolph JK Cancer Res; 1984 Sep; 44(9):3846-50. PubMed ID: 6744302 [TBL] [Abstract][Full Text] [Related]
10. Comparison of transport properties of the reduced folate carrier and folate receptor in murine L1210 leukemia cells. Sierra EE; Brigle KE; Spinella MJ; Goldman ID Biochem Pharmacol; 1995 Oct; 50(8):1287-94. PubMed ID: 7488246 [TBL] [Abstract][Full Text] [Related]
11. Interaction of probenecid with the protein binding of methotrexate. Paxton JW Pharmacology; 1984; 28(2):86-9. PubMed ID: 6709690 [TBL] [Abstract][Full Text] [Related]
12. Exchangeable intracellular methotrexate levels in the presence and absence of vincristine at extracellular drug concentrations relevant to those achieved in high-dose methotrexate-folinic acid "rescue" protocols. Goldman ID; Gupta V; White JC; Loftfield S Cancer Res; 1976 Jan; 36(1):276-9. PubMed ID: 1248006 [TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of probenecid on the individual transport routes which mediate the influx and efflux of methotrexate in L1210 cells. Henderson GB; Zevely EM Biochem Pharmacol; 1985 May; 34(10):1725-9. PubMed ID: 4004888 [TBL] [Abstract][Full Text] [Related]
14. Identification of cholate as a shared substrate for the unidirectional efflux systems for methotrexate in L1210 mouse cells. Henderson GB; Tsuji JM Biochim Biophys Acta; 1990 Jan; 1051(1):60-70. PubMed ID: 2297542 [TBL] [Abstract][Full Text] [Related]
15. Characterization of the individual transport routes that mediate the influx and efflux of methotrexate in CCRF-CEM human lymphoblastic cells. Henderson GB; Tsuji JM; Kumar HP Cancer Res; 1986 Apr; 46(4 Pt 1):1633-8. PubMed ID: 3948152 [TBL] [Abstract][Full Text] [Related]
16. Rate-limiting steps in the interactions of fluoropyrimidines and methotrexate. Bowen D; Bailey BD; Guernsey LA Eur J Cancer Clin Oncol; 1984 May; 20(5):651-7. PubMed ID: 6234172 [TBL] [Abstract][Full Text] [Related]
17. Alterations of the carrier-mediated transport of an anionic solute, methotrexate, by charged liposomes in Ehrlich ascites tumor cells. Fry DW; White JC; Goldman ID J Membr Biol; 1979 Oct; 50(2):123-40. PubMed ID: 501733 [TBL] [Abstract][Full Text] [Related]
18. K+-induced alterations of energetics and exchange diffusion in the carrier-mediated transport of the folic acid analog, methotrexate, in Ehrlich ascites tumor cells. Fry DW; Cybulski RL; Goldman ID Biochim Biophys Acta; 1980 Dec; 603(1):157-70. PubMed ID: 7192570 [TBL] [Abstract][Full Text] [Related]
19. The effects of drug transporter inhibitors on the pharmacokinetics and tissue distribution of methotrexate in normal and tumor-bearing mice: a microdialysis study. Sani SN; Henry K; Böhlke M; Kim J; Stricker-Krongrad A; Maher TJ Cancer Chemother Pharmacol; 2010 May; 66(1):159-69. PubMed ID: 19816684 [TBL] [Abstract][Full Text] [Related]
20. Enhanced polyglutamylation of aminopterin relative to methotrexate in the Ehrlich ascites tumor cell in vitro. Matherly LH; Voss MK; Anderson LA; Fry DW; Goldman ID Cancer Res; 1985 Mar; 45(3):1073-8. PubMed ID: 2578870 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]